INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 360 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,486,000 | -4.5% | 26,551 | +129.0% | 0.05% | -58.1% |
| Q3 2021 | $1,556,000 | +55.1% | 11,596 | -7.2% | 0.12% | +34.8% |
| Q1 2021 | $1,003,000 | +12.7% | 12,493 | -72.1% | 0.09% | +61.4% |
| Q3 2020 | $890,000 | +21.4% | 44,753 | +28.3% | 0.06% | +11.8% |
| Q2 2020 | $733,000 | +134.9% | 34,882 | +36.8% | 0.05% | +121.7% |
| Q1 2020 | $312,000 | +42.5% | 25,501 | +70.7% | 0.02% | +76.9% |
| Q4 2019 | $219,000 | +31.9% | 14,940 | +20.0% | 0.01% | -7.1% |
| Q3 2019 | $166,000 | -10.8% | 12,450 | +9.6% | 0.01% | -17.6% |
| Q2 2019 | $186,000 | -66.5% | 11,357 | -44.1% | 0.02% | -55.3% |
| Q2 2018 | $555,000 | – | 20,301 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |